Search

Your search keyword '"Kovač V"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Kovač V" Remove constraint Author: "Kovač V"
135 results on '"Kovač V"'

Search Results

101. Nature Versus Nurture: What Can be Learned from the Oldest-Old's Claims About Longevity?

102. Can methods of artificial intelligence aid in optimizing patient selection in patients undergoing intrauterine inseminations?

103. The Role of Cognitive Control and Rumination in Predicting Depression among Adolescents with Internalizing Disorders.

104. Antioxidants, Food Processing and Health.

105. Diagnosis and management of rudimentary horn pregnancy rupture, misinterpreted as bicornuate uterus in the 14th week of pregnancy.

106. Lost in projection - Implicit features experience of 3D architectural forms and their projections.

107. Comparison of Canine and Feline Adipose-Derived Mesenchymal Stem Cells/Medicinal Signaling Cells With Regard to Cell Surface Marker Expression, Viability, Proliferation, and Differentiation Potential.

108. Healthy Lifestyle Recommendations: Do the Beneficial Effects Originate from NAD + Amount at the Cellular Level?

109. Are Metal Ions That Make up Orthodontic Alloys Cytotoxic, and Do They Induce Oxidative Stress in a Yeast Cell Model?

110. Medical management of first trimester missed miscarriage: the efficacy and complication rate.

111. Training of adult psychiatrists and child and adolescent psychiatrists in europe: a systematic review of training characteristics and transition from child/adolescent to adult mental health services.

112. What Factors Are Associated With Neck Fracture in One Commonly Used Bimodular THA Design? A Multicenter, Nationwide Study in Slovenia.

113. Evaluation of Matrix Metalloproteinase 9 Serum Concentration as a Biomarker in Malignant Mesothelioma.

114. Failure of lumbar disc surgery: management by fusion or arthroplasty?

115. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria.

116. Causes of Massive Vulvar Edema in Patients with Severe Ovarian Hyperstimulation Syndrome: A Case Report and Literature Review.

117. Structuring new alginate network aimed for delivery of dandelion (Taraxacum officinale L.) polyphenols using ionic gelation and new filler materials.

118. Prion Proteins Without the Glycophosphatidylinositol Anchor: Potential Biomarkers in Neurodegenerative Diseases.

119. The temperament and character traits in patients with major depressive disorder and bipolar affective disorder with and without suicide attempt.

120. Endometrial injury, the quality of embryos, and blastocyst transfer are the most important prognostic factors for in vitro fertilization success after previous repeated unsuccessful attempts.

121. Clinical-pharmacogenetic models for personalized cancer treatment: application to malignant mesothelioma.

122. Truncated prion protein PrP226* - A structural view on its role in amyloid disease.

123. Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma.

124. Anchorless forms of prion protein - Impact of truncation on structure destabilization and prion protein conversion.

125. Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma.

126. Translesion polymerase genes polymorphisms and haplotypes influence survival of osteosarcoma patients.

127. Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.

128. Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.

129. Polymorphisms in translesion polymerase genes influence treatment outcome in malignant mesothelioma.

130. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.

131. Is survivin expression prognostic or predictive in malignant pleural mesothelioma?

132. DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.

133. Evaluation of coagulation abnormalities among women with vaginal bleeding in the first trimester of pregnancy.

134. The influence of gemcitabine pathway polymorphisms on treatment outcome in patients with malignant mesothelioma.

135. N,N-Dibenzoyl-ferrocenecarboxamide.

Catalog

Books, media, physical & digital resources